217 related articles for article (PubMed ID: 27169416)
1. Serum prolactin as a biomarker for the study of intracerebral dopamine effect in adult patients with phenylketonuria: a cross-sectional monocentric study.
Juhász E; Kiss E; Simonova E; Patócs A; Reismann P
Eur J Med Res; 2016 May; 21(1):22. PubMed ID: 27169416
[TBL] [Abstract][Full Text] [Related]
2. Elevated serum prolactin concentrations in phenylketonuric patients on a 'loose diet'.
Schulpis KH; Papakonstantinou E; Michelakakis H; Theodoridis T; Papandreou U; Constantopoulos A
Clin Endocrinol (Oxf); 1998 Jan; 48(1):99-101. PubMed ID: 9509074
[TBL] [Abstract][Full Text] [Related]
3. Prefrontal cortex cognitive deficits in children treated early and continuously for PKU.
Diamond A; Prevor MB; Callender G; Druin DP
Monogr Soc Res Child Dev; 1997; 62(4):i-v, 1-208. PubMed ID: 9421921
[TBL] [Abstract][Full Text] [Related]
4. The influence of blood phenylalanine levels on neurocognitive function in adult PKU patients.
Bartus A; Palasti F; Juhasz E; Kiss E; Simonova E; Sumanszki C; Reismann P
Metab Brain Dis; 2018 Oct; 33(5):1609-1615. PubMed ID: 29948654
[TBL] [Abstract][Full Text] [Related]
5. Depression, anxiety, and stress in young adults with phenylketonuria: associations with biochemistry.
Clacy A; Sharman R; McGill J
J Dev Behav Pediatr; 2014; 35(6):388-91. PubMed ID: 25007061
[TBL] [Abstract][Full Text] [Related]
6. BH4 treatment in BH4-responsive PKU patients: preliminary data on blood prolactin concentrations suggest increased cerebral dopamine concentrations.
van Vliet D; Anjema K; Jahja R; de Groot MJ; Liemburg GB; Heiner-Fokkema MR; van der Zee EA; Derks TG; Kema IP; van Spronsen FJ
Mol Genet Metab; 2015 Jan; 114(1):29-33. PubMed ID: 25466353
[TBL] [Abstract][Full Text] [Related]
7. A microplate-based enzymatic assay for the simultaneous determination of phenylalanine and tyrosine in serum.
Wibrand F
Clin Chim Acta; 2004 Sep; 347(1-2):89-96. PubMed ID: 15313145
[TBL] [Abstract][Full Text] [Related]
8. [Serum tyrosine in children with phenylketonuria and mild hyperphenylalaninemia].
Cabalska B; Nowacka M; Laskowska-Klita T; Nowaczewska I; Zorska K; Taljański W
Med Wieku Rozwoj; 2000; 4(1):5-12. PubMed ID: 11013857
[TBL] [Abstract][Full Text] [Related]
9. Large Neutral Amino Acid Therapy Increases Tyrosine Levels in Adult Patients with Phenylketonuria: A Long-Term Study.
Burlina AP; Cazzorla C; Massa P; Polo G; Loro C; Gueraldi D; Burlina AB
Nutrients; 2019 Oct; 11(10):. PubMed ID: 31640267
[TBL] [Abstract][Full Text] [Related]
10. A preliminary investigation of the role of the phenylalanine:tyrosine ratio in children with early and continuously treated phenylketonuria: toward identification of "safe" levels.
Sharman R; Sullivan K; Young R; McGill J
Dev Neuropsychol; 2010; 35(1):57-65. PubMed ID: 20390592
[TBL] [Abstract][Full Text] [Related]
11. Prolactin responses to phenylalanine and tyrosine in phenylketonuria.
Carlson HE; Hyman DB; Bauman C; Koch R
Metabolism; 1992 May; 41(5):518-21. PubMed ID: 1588831
[TBL] [Abstract][Full Text] [Related]
12. Unresponsiveness to tetrahydrobiopterin of phenylalanine hydroxylase deficiency.
Ponzone A; Porta F; Mussa A; Alluto A; Ferraris S; Spada M
Metabolism; 2010 May; 59(5):645-52. PubMed ID: 19913839
[TBL] [Abstract][Full Text] [Related]
13. Clinical characterization of tremor in patients with phenylketonuria.
Nardecchia F; Manti F; De Leo S; Carducci C; Leuzzi V
Mol Genet Metab; 2019; 128(1-2):53-56. PubMed ID: 31208951
[TBL] [Abstract][Full Text] [Related]
14. The effect of blood phenylalanine concentration on Kuvan™ response in phenylketonuria.
Elsas LJ; Greto J; Wierenga A
Mol Genet Metab; 2011 Apr; 102(4):407-12. PubMed ID: 21216643
[TBL] [Abstract][Full Text] [Related]
15. Evidence for the importance of dopamine for prefrontal cortex functions early in life.
Diamond A
Philos Trans R Soc Lond B Biol Sci; 1996 Oct; 351(1346):1483-93; discussion 1494. PubMed ID: 8941960
[TBL] [Abstract][Full Text] [Related]
16. Determination of phenylalanine and tyrosine in dried blood specimens by ion-exchange chromatography using the Hitachi L-8800 analyzer.
Allard P; Cowell LD; Zytkovicz TH; Korson MS; Ampola MG
Clin Biochem; 2004 Oct; 37(10):857-62. PubMed ID: 15369715
[TBL] [Abstract][Full Text] [Related]
17. Optimization of an HPLC method for phenylalanine and tyrosine quantization in dried blood spot.
Pecce R; Scolamiero E; Ingenito L; Parenti G; Ruoppolo M
Clin Biochem; 2013 Dec; 46(18):1892-5. PubMed ID: 24028903
[TBL] [Abstract][Full Text] [Related]
18. Glycomacropeptide in children with phenylketonuria: does its phenylalanine content affect blood phenylalanine control?
Daly A; Evans S; Chahal S; Santra S; MacDonald A
J Hum Nutr Diet; 2017 Aug; 30(4):515-523. PubMed ID: 28111827
[TBL] [Abstract][Full Text] [Related]
19. Impact of phenylalanine on cognitive, cerebral, and neurometabolic parameters in adult patients with phenylketonuria (the PICO study): a randomized, placebo-controlled, crossover, noninferiority trial.
Trepp R; Muri R; Abgottspon S; Bosanska L; Hochuli M; Slotboom J; Rummel C; Kreis R; Everts R
Trials; 2020 Feb; 21(1):178. PubMed ID: 32054509
[TBL] [Abstract][Full Text] [Related]
20. Prooxidant-antioxidant balance in patients with phenylketonuria and its correlation to biochemical and hematological parameters.
Tavana S; Amini S; Hakhamaneshi MS; Andalibi P; Hajir MS; Ardalan A; Abdi M; Fathollahpour A
J Pediatr Endocrinol Metab; 2016 Jun; 29(6):675-80. PubMed ID: 27008692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
